Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)

Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

75 Years Old and More Cancer Chemotherapy Neoplasms

Age range

75 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU

Poitiers, 86000, France

About this study

Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment:

Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient.
Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS).
Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in
Criterion analysis of D-FOG

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients aged 75 years and over
Carriers of diagnosed cancer (excluding hematology)
Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic)
Seen in nursing consultant
Beginning an oncological treatment
Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy
Patient not opposed to participate in the study

Exclusion criteria

Patients under 75 years of age
Having not had an IDE ad consultation
During oncological treatment
Receiving Oral Therapy or hormone therapy alone
Treated by radiotherapy alone or surgery alone
Not attending a day or week oncology hospital
Refusal to participate in research

Treatment and study plan

Self-questionnaire

Other

Filling of a self-questionnaire before each chemotherapy cure

Primary outcomes

Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment.

Time frame: 3 months

Feasibility of D-FOG for patients : number of D-FOGs filled in, regularity of the D-FOG self-questionnaire by the patient, number of criteria entered by D-FOG, criterion analysis of D-FOG

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Registry information

Official study title

Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment. Feasibility and Acceptability Study.

Acronym: D-FOG

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Aug 24, 2017
Registry last updated: Jan 29, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed